These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 19920784

  • 21. Effect of graded heart rate reduction with ivabradine on myocardial oxygen consumption and diastolic time in exercising dogs.
    Colin P, Ghaleh B, Monnet X, Hittinger L, Berdeaux A.
    J Pharmacol Exp Ther; 2004 Jan; 308(1):236-40. PubMed ID: 14569053
    [Abstract] [Full Text] [Related]

  • 22. Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation.
    Cappato R, Castelvecchio S, Ricci C, Bianco E, Vitali-Serdoz L, Gnecchi-Ruscone T, Pittalis M, De Ambroggi L, Baruscotti M, Gaeta M, Furlanello F, Di Francesco D, Lupo PP.
    J Am Coll Cardiol; 2012 Oct 09; 60(15):1323-9. PubMed ID: 22981555
    [Abstract] [Full Text] [Related]

  • 23. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM, Wachtell K, Kjeldsen SE, Julius S, Lindholm LH, Dahlöf B, Hille DA, Nieminen MS, Edelman JM, Devereux RB.
    Circ Arrhythm Electrophysiol; 2008 Dec 09; 1(5):337-43. PubMed ID: 19808428
    [Abstract] [Full Text] [Related]

  • 24. Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy.
    Ptaszynski P, Kaczmarek K, Ruta J, Klingenheben T, Wranicz JK.
    Europace; 2013 Jan 09; 15(1):116-21. PubMed ID: 22772053
    [Abstract] [Full Text] [Related]

  • 25. Rate control with ivabradine: angina pectoris and beyond.
    Parakh N, Bhargava B.
    Am J Cardiovasc Drugs; 2011 Jan 09; 11(1):1-12. PubMed ID: 21090826
    [Abstract] [Full Text] [Related]

  • 26. Ivabradine in combination with metoprolol succinate in the treatment of inappropriate sinus tachycardia.
    Ptaszynski P, Kaczmarek K, Ruta J, Klingenheben T, Cygankiewicz I, Wranicz JK.
    J Cardiovasc Pharmacol Ther; 2013 Jul 09; 18(4):338-44. PubMed ID: 23426376
    [Abstract] [Full Text] [Related]

  • 27. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.
    Fox K, Ford I, Steg PG, Tendera M, Ferrari R, BEAUTIFUL Investigators.
    Lancet; 2008 Sep 06; 372(9641):807-16. PubMed ID: 18757088
    [Abstract] [Full Text] [Related]

  • 28. Ivabradine, a novel heart rate slower: is it a sword of double blades in patients with idiopathic dilated cardiomyopathy?
    Rayan M, Tawfik M, Alabd A, Gamal A.
    Anadolu Kardiyol Derg; 2011 Aug 06; 11(5):402-6. PubMed ID: 21712169
    [Abstract] [Full Text] [Related]

  • 29. Heart rate reduction with ivabradine in patients with acute decompensated systolic heart failure.
    Sargento L, Satendra M, Longo S, Lousada N, dos Reis RP.
    Am J Cardiovasc Drugs; 2014 Jun 06; 14(3):229-35. PubMed ID: 24452599
    [Abstract] [Full Text] [Related]

  • 30. Heart rate reduction by I(f)-channel inhibition and its potential role in heart failure with reduced and preserved ejection fraction.
    Reil JC, Reil GH, Böhm M.
    Trends Cardiovasc Med; 2009 Jul 06; 19(5):152-7. PubMed ID: 20005474
    [Abstract] [Full Text] [Related]

  • 31. Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.
    Borer JS, Le Heuzey JY.
    Am J Ther; 2008 Jul 06; 15(5):461-73. PubMed ID: 18806523
    [Abstract] [Full Text] [Related]

  • 32. Beneficial effect of omega-3 fatty acids on sirolimus- or everolimus-induced hypertriglyceridemia in heart transplant recipients.
    Celik S, Doesch A, Erbel C, Blessing E, Ammon K, Koch A, Katus HA, Dengler TJ.
    Transplantation; 2008 Jul 27; 86(2):245-50. PubMed ID: 18645486
    [Abstract] [Full Text] [Related]

  • 33. Heart rate variability and left ventricular mass in slim children and young adults with hypertension.
    Kowalewski M, Baszuk-Stefaniuk E, Urban M, Peczyńska J.
    Kardiol Pol; 2005 Dec 27; 63(6):605-10; discussion 611-2. PubMed ID: 16380859
    [Abstract] [Full Text] [Related]

  • 34. Long-term outcomes of ivabradine in inappropriate sinus tachycardia patients: appropriate efficacy or inappropriate patients.
    Benezet-Mazuecos J, Rubio JM, Farré J, Quiñones MÁ, Sanchez-Borque P, Macía E.
    Pacing Clin Electrophysiol; 2013 Jul 27; 36(7):830-6. PubMed ID: 23510001
    [Abstract] [Full Text] [Related]

  • 35. Long-term safety and efficacy of ivabradine in patients with chronic stable angina.
    López-Bescós L, Filipova S, Martos R.
    Cardiology; 2007 Jul 27; 108(4):387-96. PubMed ID: 17890862
    [Abstract] [Full Text] [Related]

  • 36. Time-dependent changes in cardiac growth after kidney transplantation: the impact of pre-dialysis ventricular mass.
    Hernández D, González A, Rufino M, Laynez I, de la Rosa A, Porrini E, Lacalzada J, Barragán A, Lorenzo V, Torres A.
    Nephrol Dial Transplant; 2007 Sep 27; 22(9):2678-85. PubMed ID: 17510095
    [Abstract] [Full Text] [Related]

  • 37. Selective and specific I(f) inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease.
    Ferrari R, Ceconi C.
    Expert Rev Cardiovasc Ther; 2011 Aug 27; 9(8):959-73. PubMed ID: 21878041
    [Abstract] [Full Text] [Related]

  • 38. Ivabradine induces an increase in ventricular fibrillation threshold during acute myocardial ischemia: an experimental study.
    Vaillant F, Timour Q, Descotes J, Manati W, Belhani D, Bui-Xuan B, Tabib A, Bricca G, Chevalier P.
    J Cardiovasc Pharmacol; 2008 Dec 27; 52(6):548-54. PubMed ID: 19034029
    [Abstract] [Full Text] [Related]

  • 39. Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction.
    Heusch G, Skyschally A, Gres P, van Caster P, Schilawa D, Schulz R.
    Eur Heart J; 2008 Sep 27; 29(18):2265-75. PubMed ID: 18621770
    [Abstract] [Full Text] [Related]

  • 40. Ivabradine as a heart rate-lowering agent in a patient with end-stage renal failure after heart transplantation.
    Kurpesa M, Trzos E, Wierzbowska-Drabik K, Rechciński T.
    Kardiol Pol; 2010 Jun 27; 68(6):684-6. PubMed ID: 20806202
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.